Viral Proteases

Viral proteases are essential enzymes that play a critical role in the life cycle of many viruses. These enzymes are responsible for cleaving large viral precursor polyproteins into functional, mature proteins required for viral replication and assembly. By targeting viral proteases, researchers have made significant strides in developing antiviral therapies.

Viral Proteases and Their Functions

Viral proteases are enzymes that catalyze the cleavage of specific peptide bonds within viral polyproteins. These polyproteins are translated from viral RNA and serve as precursors for essential viral proteins.

a. Proteolytic processing by viral proteases is a crucial step in the viral life cycle, as it generates functional viral proteins necessary for various stages of replication. The primary functions of viral proteases include:a. Maturation of viral proteins: Viral proteases cleave precursor polyproteins to release individual proteins required for viral replication, such as structural proteins and enzymes.

b. Virion assembly: Proteolytic processing is critical for the assembly of new viral particles. Cleaved proteins come together to form mature virions.

c. Immune evasion: Some viral proteases can cleave host immune proteins, helping the virus evade the host's immune response.

2. Types of Viral Proteases:

There are two main types of viral proteases:

a. Serine proteases: Common in picornaviruses and flaviviruses, serine proteases require a serine residue in their active site for catalysis.

b. Cysteine proteases: Found in a wide range of viruses, including retroviruses and coronaviruses, cysteine proteases use a cysteine residue in their active site.

3. Targeting Viral Proteases for Antiviral Therapies:

Given their critical role in viral replication, viral proteases have become attractive targets for antiviral drug development. Several successful antiviral drugs have been designed to inhibit viral proteases, including:

a. HIV protease inhibitors: Drugs like ritonavir and lopinavir inhibit the protease enzyme of the human immunodeficiency virus (HIV), preventing the maturation of the virus and slowing down disease progression.

b. HCV protease inhibitors: In the case of hepatitis C virus (HCV), drugs like telaprevir and boceprevir target the viral protease NS3-4A, effectively suppressing viral replication.

c. COVID-19 protease inhibitors: During the COVID-19 pandemic, researchers have explored protease inhibitors like remdesivir to target the main protease (Mpro) of the SARS-CoV-2 virus, with promising results.

We are using the BRET technology to develop molecular biosensors for the protease activity of several highly-pathogenic viruses. Such biosensors are capable of generating in real time a specific signal due to protease activity in living cells and are ideal tools to identify novel protease inhibitors to fight viral infections and to study virus-host interactions by enabling researchers to monitor viral replication using protease activity as a surrogate,

REFERENCES

1. Zheng, Y., et al., Lysosomal Proteases Are a Determinant of Coronavirus Tropism. J Virol, 2018. 92(24).

2. Hoffmann, M., et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 2020.

3. Debouck, C., The HIV-1 protease as a therapeutic target for AIDS. AIDS Res Hum Retroviruses, 1992. 8(2): p. 153-64.

4. Bartenschlager, R., The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy. J Viral Hepat, 1999. 6(3): p. 165-81.

5. Bacart, J., et al., The BRET technology and its application to screening assays. Biotechnol J, 2008. 3(3): p. 311-24.

6. Konvalinka, J., H.G. Krausslich, and B. Muller, Retroviral proteases and their roles in virion maturation.Virology, 2015. 479-480: p. 403-17.